BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chaddha U, Agrawal A, Feller-Kopman D, Kaul V, Shojaee S, Maldonado F, Ferguson MK, Blyth KG, Grosu HB, Corcoran JP, Sachdeva A, West A, Bedawi EO, Majid A, Mehta RM, Folch E, Liberman M, Wahidi MM, Gangadharan SP, Roberts ME, DeCamp MM, Rahman NM. Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement. Lancet Respir Med 2021;9:1050-64. [PMID: 33545086 DOI: 10.1016/S2213-2600(20)30533-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Lau EP, Eshraghi M, Dootson K, Yeoh C, Ywe Phu W, Lee YG, Popowicz ND. An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection. ERJ Open Res 2022;8:00590-2021. [DOI: 10.1183/23120541.00590-2021] [Reference Citation Analysis]
2 Federici S, Bédat B, Hayau J, Gonzalez M, Triponez F, Krueger T, Karenovics W, Perentes JY. Outcome of parapneumonic empyema managed surgically or by fibrinolysis: a multicenter study. J Thorac Dis 2021;13:6381-9. [PMID: 34992818 DOI: 10.21037/jtd-21-1083] [Reference Citation Analysis]
3 Luque Paz D, Bayeh B, Chauvin P, Poizeau F, Lederlin M, Kerjouan M, Lefevre C, de Latour B, Letheulle J, Tattevin P, Jouneau S. Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: A comparative cohort study. PLoS One 2021;16:e0257339. [PMID: 34547022 DOI: 10.1371/journal.pone.0257339] [Reference Citation Analysis]
4 Popowicz N, Ip H, Lau EPM, Piccolo F, Dootson K, Yeoh C, Phu WY, Brown R, West A, Ahmed L, Lee YCG. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose. Respirology 2022. [PMID: 35441458 DOI: 10.1111/resp.14261] [Reference Citation Analysis]
5 Karandashova S, Florova G, Idell S, Komissarov AA. From Bedside to the Bench—A Call for Novel Approaches to Prognostic Evaluation and Treatment of Empyema. Front Pharmacol 2022;12:806393. [DOI: 10.3389/fphar.2021.806393] [Reference Citation Analysis]
6 Beckert L, de Koning Gans JM, Maze MJ. Ubi pus, ibi evacua: Optimizing intrapleural fibrinolytic therapy in pleural infections. Respirology 2022. [PMID: 35560748 DOI: 10.1111/resp.14293] [Reference Citation Analysis]
7 Sorino C, Mondoni M, Lococo F, Marchetti G, Feller-Kopman D. Optimizing the management of complicated pleural effusion: From intrapleural agents to surgery. Respir Med 2021;191:106706. [PMID: 34896966 DOI: 10.1016/j.rmed.2021.106706] [Reference Citation Analysis]